Table III.
Multivessel PCI N=256,865 |
Hybrid PCI/CABG N=1,126 |
p-value | |
---|---|---|---|
Demographics | |||
Age (years) | 66 (58–75) | 65 (58–72) | <0.001 |
Female | 32.0% | 29.6% | 0.08 |
Non-white race | 14.1% | 14.8% | 0.47 |
Uninsured | 4.5% | 7.3% | <0.001 |
History and Risk Factors | |||
BMI | 29.1 (25.7–33.3) | 29.0 (25.8–33.1) | 0.95 |
Prior MI | 29.0% | 25.9% | 0.02 |
Previous PCI | 38.9% | 25.7% | <0.001 |
Diabetes | 41.2% | 41.5% | 0.87 |
Cerebrovascular disease | 13.3% | 14.0% | 0.45 |
Hypertension | 85.4% | 84.2% | 0.23 |
Dyslipidemia | 81.6% | 80.0% | 0.002 |
Creatinine clearance (mL/min) | 65.0 (46.4–84.8) | 68.4 (49.6–87.0) | 0.002 |
Presentation | |||
ACS: NSTEMI | 26.0% | 42.9% | <0.001 |
ACS: Unstable Angina | 45.7% | 40.0% | |
Stable Angina | 17.6% | 8.7% | |
Atypical Chest Pain | 2.7% | 1.1% | |
No Angina | 8.0% | 7.4% | |
Cardiac arrest* | 0.4% | 1.4% | <0.001 |
Ejection Fraction <40% | 11.7% | 12.3% | 0.45 |
LM or Prox LAD Lesion | 42.9% | 69.8% | <0.001 |
3VD (vs. 2VD) | 31.6% | 60.0% | <0.001 |
PCI Complexity | |||
Number of lesions treated | 2.0 (2.0, 3.0) |
1.0 (1.0, 2.0) |
<0.001 |
Lesion length | 16.0 (12.0–24.0) | 18.0 (12.0–26.0) | 0.007 |
CTO | 36.3% | 11.9% | <0.001 |
Pre-procedure TIMI 0/1 | 13.2% | 32.2% | <0.001 |
High/Type C lesion | 50.8% | 58.1% | <0.001 |
Bifurcation lesion | 11.6% | 9.9% | 0.09 |
Drug-eluting stent | 89.9% | 67.1% | <0.001 |
Discharge P2Y12 inhibitor | |||
Overall | 98.0% | 83.1% | <0.001 |
Clopidogrel | 73.1% | 78.1% | <0.001 |
Prasugrel | 15.4% | 2.7% | <0.001 |
Ticagrelor | 10.2% | 6.3% | <0.001 |
BMI: Body Mass Index
MI: Myocardial Infarction
PCI: Percutaneous Coronary Intervention
ACS: Acute Coronary Syndrome
LM: Left Main
LAD: Left Anterior Descending
IABP: Intra-aortic Balloon Pump
Cardiac arrest within 24 hours of presentation to cardiac catheterization lab
Missing data excluded; all fields with <1% missing data with exception of LM/LAD stenosis